fda gilead - Search News

News

FDA Approves Gilead’s HIV Shot. It Works 99.9% of Time.

USA TODAY on MSN · 11h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Barron's on MSN · 1d

FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.

The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and called Yeztugo,

Times Now on MSN · 46m

US FDA Approves Revolutionary New HIV Drug That Offers 99.9 Percent Protection

The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical trials, the drug nearly eliminated HIV’s spread among those given an injection every six months.

Fierce Pharma1d

FDA signs off on Gilead's landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

1d

Should You Buy Gilead Stock At $110?

Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results